Irreversible ErbB-family tyrosine kinase inhibitor

Afatinib (أفاتينيب)

Afatinib is a targeted treatment that blocks growth signals in selected lung cancers. It is prescribed by an oncology specialist after appropriate testing and can cause severe diarrhoea, rash, and lung or liver problems requiring early action.

This medicine is used under close medical supervision, usually by a specialist. Never start, stop or change it without your doctor.

What it is used for

  • Treating advanced non-small-cell lung cancer with activating EGFR mutations
  • Treating selected advanced squamous-cell lung cancers that progressed after previous treatment
  • Use as monotherapy under oncology-specialist supervision

How it is used

  • Swallow the tablet with water on an empty stomach as directed by the oncology specialist
  • If swallowing is difficult, the tablet may be dispersed in still water exactly as the leaflet directs without crushing it
  • Do not change or stop treatment yourself; the specialist may interrupt or adjust it for side effects
  • Start the anti-diarrhoeal treatment supplied by your team at the first sign and contact them if diarrhoea persists or becomes severe

Possible side effects

  • Diarrhoea that can become severe and cause dehydration and kidney problems
  • Rash or acne-like spots, dry skin and itching
  • A sore or ulcerated mouth and reduced appetite
  • Inflammation around the nails
  • Changes in liver function or, rarely, lung inflammation

Who should not use it

  • Allergy to afatinib or any ingredient in the product

Before and while using it

  • Contact the oncology team early for diarrhoea because dehydration can become serious
  • Report new or worsening breathlessness, cough or fever immediately because of possible lung inflammation
  • Moisturise and protect skin from sunlight; rash may need early treatment
  • Tell your clinician about eye pain, redness, light sensitivity or a vision change
  • Liver monitoring and heart or kidney assessment are needed when risk factors are present
  • Exposure can be higher in people with low body weight, women or kidney impairment, requiring closer monitoring

Medicine interactions

  • Some epilepsy and tuberculosis medicines and St John's wort can reduce its effect
  • Some medicines that inhibit drug transporters can increase exposure and may require separation or a plan adjustment
  • Tell the oncology team about every medicine and supplement before starting

Pregnancy and breastfeeding

  • It may harm an unborn baby; use effective contraception during treatment and for the period specified afterwards, and tell the oncology team immediately if pregnancy is possible
  • Do not breastfeed during treatment

How to store it

  • Keep in the original package to protect from moisture and light and out of children's reach

Get medical help straight away if

  • Your face, lips or tongue swell, or you find it hard to breathe.
  • You get a severe rash, blistering or peeling skin.
  • A side effect worries you or doesn’t go away: contact your doctor or pharmacist.

Questions about this medicine?

Talk to a doctor by video, or send your question by text.

Source: Standard international medicine references

This guide is general information and doesn’t replace advice from your doctor or pharmacist. Don’t start, stop or change a medicine without asking them, and always read the leaflet in the pack.